The 52 Week Low is $49.24 set on Fri, Mar 20, 2020.
The 52 Week High is $69.75 set on Thu, Sep 17, 2020.
The All-Time High is $69.75 set on Thu, Sep 17, 2020.
Earnings Per Share
Price To Earnings Ratio
Dividend Payment Date
Novo Nordisk A/S trades on the NYSE. NVO's market cap is 158.8 Billion.
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.